KRAIG BIOCRAFT LABORATORIES, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-5.3M | — |
| FY2022 | — | $-3.5M | $3.9M |
| FY2023 | — | $-5.7M | $2.6M |
| FY2024 | — | $-8.1M | $673.3K |
| FY2025 | — | $-8.0M | $1.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-5.3M | — |
| FY2022 | — | $-3.5M | $3.9M |
| FY2023 | — | $-5.7M | $2.6M |
| FY2024 | — | $-8.1M | $673.3K |
| FY2025 | — | $-8.0M | $1.8M |